Carotenoid

Carotenoid

Best for

Protect against macular degeneration

Promising early signal · 22–50 mg/day for 52–78 weeks · 3 studies , n=21.2k

9 papers · 6 claims · 22 outcomes scored · 6 positive

Outcomes

What carotenoid actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect Evidence Dose Weeks Rank
Protect against macular degeneration Promising early signal
moderate
3 RCTs n=21k 22–50 mg 52–78 wk #4/6
Build eye-protective pigment stores Promising early signal
moderate
2 meta-analyses n=— Meta-analyzed 5 g 4–17 wk #2/5
Raise protective carotenoid levels Likely modest benefit
small
1 meta-analysis n=— Meta-analyzed 8 wk #2/7
Build firmer, denser skin Not enough research
trivial
1 meta-analysis n=71 Meta-analyzed #8/8
Sharpen visual clarity Not enough research
trivial
1 RCT n=47 22 mg 78 wk #3/4
Protect vision in retinal disease Not enough research
trivial
1 RCT n=47 22 mg 78 wk #3/5
Buy well

Recommended Carotenoid products

Real products that dose Carotenoid where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.

Chosen for adequate Carotenoid dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.

Risk profile

Adverse events and known drug interactions

Safety events

lung_cancer severe
intracerebral_hemorrhage severe
cardiovascular_disease severe
pneumonia severe
hepatotoxicity severe
hyperlipidemia moderate
common_cold mild

Drug interactions

Cyclosporine major decreases concentration
Antineoplastic Agents major decreases effect
Nelfinavir minor unknown

Co-studied with

Supplements that share evidence with carotenoid

Want personalized recommendations?

Show me what works for me